Concepedia
Statistics
Publications
25
Citations
1.8K
H-Index
21
Active since
1980
Affiliations
Deutsche Telekom (United Kingdom)(Current)
Burn Institute
Andover Eye Associates
VIR Biotechnology (United States)
Massachusetts Institute of Technology
Brian D. Kelley is an author at Deutsche Telekom (United Kingdom) specializing in biochemistry, life sciences, and pharmacy.
Publications per year
1980–2024
High‐throughput screening of chromatographic separations: I. Method development and column modeling
Jon Coffman, Jack F. Kramarczyk, Brian D. Kelley · Biotechnology and Bioengineering · 2008 · 212 citations · Full text
Pharmacy, Biochemistry, Pharmaceutical Analysis +17
Developing therapeutic monoclonal antibodies at pandemic pace
Brian D. Kelley · Nature Biotechnology · 2020 · 172 citations · Full text
Pharmacy, Pharmaceutical Biotechnology, Pharmacology +14
Weak partitioning chromatography for anion exchange purification of monoclonal antibodies
Brian D. Kelley, Scott A. Tobler, Paul Brown et al. · Biotechnology and Bioengineering · 2008 · 145 citations
Life Sciences, Biochemistry, Biotechnology +17
High‐throughput screening of chromatographic separations: IV. Ion‐exchange
Brian D. Kelley, Mary Switzer, Patrick Bastek et al. · Biotechnology and Bioengineering · 2008 · 127 citations
Pharmacy, Chemical Engineering, Chemistry +17
High‐throughput screening of chromatographic separations: II. Hydrophobic interaction
Jack F. Kramarczyk, Brian D. Kelley, Jon Coffman · Biotechnology and Bioengineering · 2008 · 123 citations
Pharmacy, Biochemistry, Analytical Chemistry +16
1–5 of 25